The global Sepsis Diagnostics industry is experiencing steady expansion driven by the rising clinical urgency for rapid infection detection and early therapeutic intervention. The Sepsis Diagnostics Market is projected to increase from US$ 844 million in 2025 to US$ 1558.98 million by 2034, registering a CAGR of 7.06% during 2026–2034. This growth is primarily supported by the increasing burden of sepsis cases worldwide, particularly those linked to hospital-acquired infections. Healthcare systems are increasingly adopting advanced diagnostic tools that significantly reduce turnaround time and improve patient survival rates. Sepsis diagnostics have evolved from conventional culture-based methods to integrated molecular and biomarker-driven solutions used in critical care environments. Key Market Drivers and Challenges A major driver of the Sepsis Diagnostics Market is the rising incidence of hospital-acquired infections, which continue to be a leading...